3.9 Article

Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer

期刊

ARCHIVES OF SURGERY
卷 142, 期 7, 页码 649-655

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/archsurg.142.7.649

关键词

-

类别

向作者/读者索取更多资源

Hypothesis: Despite the noninclusion of locally draining lymph nodes, limited resection of low-risk pT1 rectal cancer can achieve an adequate oncological outcome with lower morbidity and mortality compared with radical resection. Design: Based on the data of a prospective multicenter observational study performed from January 1, 2000, through December 31, 2001, patients with low-risk pT1 rectal cancer underwent analysis with regard to the early postoperative outcome and the oncological long-term results achieved after limited vs radical resection with curative intent. Setting: Two hundred eighty-two hospitals of all categories. Patients: Four hundred seventy-nine patients with low-risk pT1 rectal cancer treated for cure. Interventions: Eighty-five patients (17.7%) underwent limited excision using a conventional transanal approach and 35 (7.3%) using transanal endoscopic microsurgery. The remaining 359 (74.9%) underwent radical resection. Main Outcome Measures: Postoperative morbidity and mortality, local recurrence rate, and tumor-free and overall survival. Results: In comparison with radical resection, limited resection was associated with fewer general (25.1% vs 7.5%; P < .001) and specific (22.8% vs 9.2%; P < .001) postoperative complications. After a mean follow-up of 44 months, patients who underwent limited resection had a significantly higher 5-year local tumor recurrence rate than did those who underwent radical resection (6.0% vs 2.0%; P = .049), but tumor-free survival did not differ. Conclusion: Limited resection of pT1 low-risk rectal cancer can result in an oncologically acceptable outcome but must nevertheless be considered an oncological compromise compared with radical resection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据